Starling Oncology, Inc.
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 59.1M |
| FY2021 | 66.2M |
| FY2022 | 80.6M |
| FY2023 | 73.7M |
| FY2024 | 75.0M |
Shares Outstanding
| Fiscal Year | Shares Outstanding |
|---|---|
| FY2020 | 59.1M |
| FY2021 | 66.2M |
| FY2022 | 80.6M |
| FY2023 | 73.7M |
| FY2024 | 75.0M |